Bromide

Bromide

SCHEMBL3863605

Br.CCOC(=O)Cn1c2c(sc1=N)CCCC2

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRA2A known ✓ P08913 1/20 0.36
▸ ADRA2B known ✓ P18089 1/20 0.36
▸ ADRA2C known ✓ P18825 1/20 0.36
▸ CYP1A1 P04798 2/20 0.60
▸ CYP1B1 Q16678 2/20 0.60
▸ ALDH1A1 P00352 5/20 0.58
▸ MAPK1 P28482 4/20 0.58
▸ HSD17B10 Q99714 4/20 0.58
▸ MAPT P10636 3/20 0.58
▸ TSHR P16473 3/20 0.58
▸ MEN1 O00255 2/20 0.58
▸ KMT2A Q03164 2/20 0.58
▸ ALOX15 P16050 2/20 0.58
▸ TP53 P04637 2/20 0.58
▸ CYP3A4 P08684 1/20 0.58
▸ SMN1; SMN2 Q16637 1/20 0.58
▸ HDAC6 Q9UBN7 1/20 0.58
▸ LMNA P02545 4/20 0.56
▸ KDM4E B2RXH2 3/20 0.45
▸ HPGD P15428 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3863610 0.99 ALDH1A1 (0.60) CYP1A1CYP1B1ALDH1A1MAPK1HSD17B10
SCHEMBL4938578 0.85 ALDH1A1 (0.59) CYP1A1CYP1B1ALDH1A1MAPK1HSD17B10
SCHEMBL4940049 0.79 MAPT (0.69) CYP1A1CYP1B1ALDH1A1MAPK1HSD17B10
SCHEMBL158627 0.74 KMT2A (1.00) CYP1A1CYP1B1ALDH1A1MAPK1HSD17B10
SCHEMBL4942644 0.74 KMT2A (0.53) CYP1A1CYP1B1ALDH1A1MAPK1HSD17B10
Bromide SCHEMBL22749617 0.73 CYP1A1 (0.77) CYP1A1CYP1B1ALDH1A1MAPK1HSD17B10
Bromide SCHEMBL22749605 0.72 KMT2A (0.95) CYP1A1CYP1B1ALDH1A1MAPK1HSD17B10
SCHEMBL4940475 0.72 KMT2A (0.51) CYP1A1CYP1B1ALDH1A1MAPK1HSD17B10
SCHEMBL15033505 0.71 LMNA (0.97) ALDH1A1MAPK1HSD17B10MAPTTSHR
SCHEMBL4941189 0.71 MAPT (0.76) CYP1A1CYP1B1ALDH1A1MAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7601846-B2 Compounds having activity as inhibitors of apoptosis THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-10-13 — — US disclosed
US-20060122178-A1 Compounds having activity as inhibitors of apoptosis REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE 2006-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122178-A1 Compounds having activity as inhibitors of apoptosis BAD, CASP3, BAX ADRA2A 4569/4885ADRA2B 4444/4885ADRA2C 4557/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback